Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop.
D000584:Amiloride / Q000627:therapeutic use*; D002192:Canrenone / Q000627:therapeutic use*; D006801:Humans; D007684:Kidney Tubules / Q000503:physiopathology*; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000503:physiopathology; D008138:Loop of Henle / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000652:urine*; D011245:Pregnadienes / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*; D012964:Sodium / Q000652:urine*; D013148:Spironolactone / Q000627:therapeutic use*; D014223:Triamterene / Q000627:therapeutic use*
D011245:Pregnadienes; D011719:Pyrazines; D013148:Spironolactone; D002192:Canrenone; D000584:Amiloride; D012964:Sodium; D011188:Potassium; D014223:Triamterene